Logo

PhyNexus Signs Deal for Qiagen Resin

Sep 27, 2004

NEW YORK, Sept. 27 (GenomeWeb News) - PhyNexus said today that it has signed a deal under which Qiagen has granted PhyNexus the right to incorporate Qiagen's Ni-NTA resin for the purification of His-tagged protein.

 

According to PhyNexus, the Qiagen resin will be used in its PhyTip columns, which are specifically designed for micro volume protein purification and enrichment. Additional terms of the deal were not disclosed.

 

Breaking News
The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.